Skip to content

On this page

Egrifta

tesamorelin

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Egrifta

Proper name

tesamorelin

Licence type

351(a)

BLA number

022505

Applicant

Theratechnologies Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
1MG	For Injection	Subcutaneous	Single-Dose Vial	Disc	November 10, 2010

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity